Schroder Investment Management Group Alector, Inc. Transaction History

Schroder Investment Management Group

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$6.88 - $9.55 $55,328 - $76,801	8,042 Added 3.97%	210,665 $1.94 Million
Q3 2022 Nov 10, 2022	SELL	$8.19 - $13.2 $1.01 Million - $1.62 Million	-122,950 Reduced 37.76%	202,623 $1.92 Million
Q2 2022 Aug 11, 2022	SELL	$7.65 - $14.24 $1.11 Million - $2.06 Million	-144,464 Reduced 30.73%	325,573 $3.32 Million
Q1 2022 May 16, 2022	BUY	$13.02 - $20.78 $2.84 Million - $4.53 Million	218,041 Added 86.53%	470,037 $6.82 Million
Q4 2021 Feb 14, 2022	BUY	$19.35 - $25.54 $1.77 Million - $2.34 Million	91,681 Added 57.19%	251,996 $5.2 Million
Q3 2021 Nov 12, 2021	BUY	$21.65 - $39.49 $251,226 - $458,241	11,604 Added 7.8%	160,315 $3.66 Million
Q2 2021 Aug 13, 2021	BUY	$15.5 - $22.48 $2.31 Million - $3.34 Million	148,711 New	148,711 $3.1 Million

167

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $149M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.